Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88.
Zhang Q, Zhu W, Lou S, Bao H, Zhou Y, Cai Z, Ye J, Cui Y, Wang M, Jin L, Liang G, Luo W, Wang Y.
Zhang Q, et al. Among authors: wang y, wang m.
Int Immunopharmacol. 2023 Nov;124(Pt A):110863. doi: 10.1016/j.intimp.2023.110863. Epub 2023 Sep 11.
Int Immunopharmacol. 2023.
PMID: 37703787